Flexible docking, synthesis and biological evaluation of N-[(4-pyrazolyl)cyclopropylmethyl] cyclic ureas as HIV protease inhibitors.

被引：0
|
作者：
Han, W [1 ]
Hu, ZL [1 ]
Pelletier, J [1 ]
Rossi, KA [1 ]
Hodge, CN [1 ]
机构：
[1] Dupont Merck Pharmaceut Co, Wilmington, DE 19880 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 215卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
026-MEDI
引用
收藏
页码：U868 / U868
页数：1
相关论文
共 50 条
  • [21] Racemic and enantioselective synthesis of enol-lactone and their biological activity as potent HIV-1 protease inhibitors.
    Ibrahimi, S
    Sauvé, G
    Yelle, J
    Essassi, E
    COMPTES RENDUS CHIMIE, 2005, 8 (01) : 75 - 83
  • [22] Design, synthesis, and biological evaluation of novel 4-hydroxypyrone derivatives as HIV-1 protease inhibitors
    Sun, CL
    Pang, RF
    Zhang, H
    Yang, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (13) : 3257 - 3262
  • [23] Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV-1 Protease Inhibitors
    Rehman, Muhammad Asad Ur
    Chuntakaruk, Hathaichanok
    Amphan, Soraat
    Suroengrit, Aphinya
    Hengphasatporn, Kowit
    Shigeta, Yasuteru
    Rungrotmongkol, Thanyada
    Krusong, Kuakarun
    Boonyasuppayakorn, Siwaporn
    Aonbangkhen, Chanat
    Khotavivattana, Tanatorn
    ACS BIO & MED CHEM AU, 2024, 4 (05): : 242 - 256
  • [24] Structure-based design, synthesis, and biological evaluation of RGS4 inhibitors.
    Jin, YF
    Zhong, HL
    Omnaas, JR
    Neubig, RR
    Mosberg, HI
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U39 - U39
  • [25] Synthesis, Molecular Docking Studies and Biological Evaluation of N-(α-Benzamido Cinnamoyl) Piperonal Hydrazones
    Saritha, Karnati
    Devi, Tangirala Sarala
    Rani, Murthi Vidya
    Kumar, Katari Sudheer
    Umamaheswari, Amineni
    Rajitha, Galla
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (13) : 2711 - 2727
  • [26] Novel inhibitors of HIV protease: Design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds
    Spaltenstein, A
    Almond, MR
    Bock, WJ
    Cleary, DG
    Furfine, ES
    Hazen, RJ
    Kazmierski, WM
    Salituro, FG
    Tung, RD
    Wright, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1159 - 1162
  • [27] Cyclic HIV protease inhibitors:: Design and synthesis of orally bioavailable, pyrazole P2/P2′ cyclic ureas with improved potency
    Han, Q
    Chang, CH
    Li, RH
    Ru, Y
    Jadhav, PK
    Lam, PYS
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) : 2019 - 2028
  • [28] Environmentally benign synthesis of unsymmetrical ureas and their evaluation as potential HIV-1 protease inhibitors via a computational approach
    Tsenbeni N. Lotha
    Kikoleho Richa
    Viphrezolie Sorhie
    Vevosa Ketiyala
    Vimha Nakro
    Lemzila Imkongyanger
    Nima D. Ritse
    Latonglila Rudithongru
    Molecular Diversity, 2024, 28 : 749 - 763
  • [29] Environmentally benign synthesis of unsymmetrical ureas and their evaluation as potential HIV-1 protease inhibitors via a computational approach
    Lotha, Tsenbeni N. N.
    Richa, Kikoleho
    Sorhie, Viphrezolie
    Nakro, Vevosa
    Ritse, Vimha
    Rudithongru, Lemzila
    Namsa, Nima D. D.
    Jamir, Latonglila
    MOLECULAR DIVERSITY, 2024, 28 (02) : 749 - 763
  • [30] Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors
    Hameed, Abdul
    Khan, Khalid Mohammed
    Zehra, Syeda Tazeen
    Ahmed, Ramasa
    Shafiq, Zahid
    Bakht, Syeda Mahwish
    Yaqub, Muhammad
    Hussain, Mazhar
    de Len, Antonio de la Vega
    Furtmann, Norbert
    Bajorath, Juergen
    Shad, Hazoor Ahmad
    Tahir, Muhammad Nawaz
    Iqbal, Jamshed
    BIOORGANIC CHEMISTRY, 2015, 61 : 51 - 57
12345